Skip to Content

The Impossible Burger is coming to a shop (and a Burger King) near you

August 1, 2019
A meat-free "bleeding" burger
A meat-free "bleeding" burgerAssociated Press

US regulators have approved a key ingredient in Impossible Foods’ plant-based burger patties, clearing the way for them to go on sale directly to consumers.

The news: The US Food and Drug Administration has ruled that soy leghemoglobin, a protein-based color additive used to make the Impossible Burger “bleed” like real meat, is safe, Reuters reports. Impossible Foods has said its burger will go on sale in “select retail stores” in September.

The magic ingredient: Soy leghemoglobin, also called “heme,” is found in the root nodules of plants and closely resembles hemoglobin, an iron-containing protein found in red blood cells. Impossible Foods uses genetic engineering to scale up the volumes of heme for production.

I’m hungry, can I get one? Extra good news, burger fans. If you live in the US, you’ll be able to buy an Impossible Whopper from any of Burger King’s 7,200 outlets a week from today. The fast food chain (following in the footsteps of rival White Castle) carried out a trial run in St. Louis earlier this year. Visit to those branches rose by more than 18%, TechCrunch reports. No wonder the chain is keen to roll it out nationwide.

Why is the burger in restaurants but not stores? It's down to the way food is regulated in the US. The FDA regulates all foods and food ingredients, but it doesn't have any jurisdiction over restaurants, cafeterias or food trucks, which are regulated by state and local governments. 

Read next: The race to make a lab-grown steak

This story first appeared in our daily newsletter The Download. Sign up here to get your dose of the latest must-read news from the world of emerging tech.

Deep Dive


A brain implant changed her life. Then it was removed against her will.

Her case highlights why we need to enshrine neuro rights in law.

The first babies conceived with a sperm-injecting robot have been born

Meet the startups trying to engineer a desktop fertility machine.

Doctors have performed brain surgery on a fetus in one of the first operations of its kind

A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.

The FDA just approved rub-on gene therapy that helps “butterfly” children

Biotech companies are getting creative with how they deliver DNA fixes into people's bodies.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.